Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema
Background: Hereditary angioedema (HAE) is a rare but life-threatening condition. HAE types I and II (HAE-1/2) result from C1-inhibitor (C1–INH) deficiency. However, recent genetic analysis has established a new type of HAE with normal C1–INH (HAEnC1-INH). The mutations of factor XII, plasminogen, a...
Main Authors: | Isao Ohsawa, Atsushi Fukunaga, Shinya Imamura, Kazumasa Iwamoto, Akio Tanaka, Michihiro Hide, Daisuke Honda, Kouhei Yamashita, Chisako Fujiwara, Osamu Ishikawa, Takeo Yamaguchi, Junichi Maehara, Tomoya Hirose, Masahiro Ieko, Kunihiko Umekita, Yuya Nakamura, Hiromichi Gotoh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | World Allergy Organization Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455121000053 |
Similar Items
-
Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
by: Michihiro Hide, et al.
Published: (2021-01-01) -
Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
by: Werner Aberer, et al.
Published: (2017-07-01) -
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
by: Teresa Caballero, et al.
Published: (2018-03-01) -
Life-threatening angioedema induced by angiotensin-converting enzyme inhibitor: two case reports
by: Erik Rupnik, et al.
Published: (2016-01-01) -
Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom
by: Hilary J. Longhurst, et al.
Published: (2018-08-01)